Scientific instrument company Bruker (NASDAQ: BRKR). will be reporting results this Monday before the bell. Here’s what you need to know.
Bruker missed analysts’ revenue expectations by 1.5% last quarter, reporting revenues of $797.4 million, flat year on year. It was a disappointing quarter for the company, with a significant miss of analysts’ full-year EPS guidance estimates and a significant miss of analysts’ EPS estimates.
Is Bruker a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Bruker’s revenue to decline 2.1% year on year to $845.7 million, a reversal from the 16.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.32 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Bruker has missed Wall Street’s revenue estimates four times over the last two years.
Looking at Bruker’s peers in the research tools & consumables segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Thermo Fisher delivered year-on-year revenue growth of 4.9%, beating analysts’ expectations by 1.9%, and Revvity reported revenues up 2.2%, in line with consensus estimates. Thermo Fisher traded up 2.6% following the results while Revvity was down 2.4%.
Read our full analysis of Thermo Fisher’s results here and Revvity’s results here.
Investors in the research tools & consumables segment have had steady hands going into earnings, with share prices flat over the last month. Bruker is up 5.2% during the same time and is heading into earnings with an average analyst price target of $46.45 (compared to the current share price of $38.90).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
